Incidence Rate of Cardiovascular Events in Rheumatoid Arthritis: An Observational Cohort Study in Saudi Arabia

References

• Singh JA, Saag KG, Bridges SL, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2016;68(1):1–25. doi:10.1002/acr.22783
   PubMed Web of Science ®Google Scholar
• Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021;41(5):863–877. doi:10.1007/s00296-020-04731-0
   PubMed Web of Science ®Google Scholar
• Peters MJL, Symmons DPM, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69(2):325–331. doi:10.1136/ard.2009.113696
   PubMed Web of Science ®Google Scholar
• Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71(9):1524–1529. doi:10.1136/annrheumdis-2011-200726
   PubMed Web of Science ®Google Scholar
• Mantel Ä, Holmqvist M, Andersson DC, Lund LH, Askling J. Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure. J Am Coll Cardiol. 2017;69(10):1275–1285. doi:10.1016/j.jacc.2016.12.033
   PubMed Web of Science ®Google Scholar
• DeMizio DJ, Geraldino-Pardilla LB. Autoimmunity and inflammation link to cardiovascular disease risk in rheumatoid arthritis. Rheumatol Ther. 2020;7(1):19–33. doi:10.1007/s40744-019-00189-0
   PubMed Web of Science ®Google Scholar
• Prasad M, Hermann J, Gabriel SE, et al. Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol. 2015;12(3):168–176. doi:10.1038/nrcardio.2014.206
   PubMed Web of Science ®Google Scholar
• Murdaca G, Colombo BM, Cagnati P, Gulli R, Spanò F, Puppo F. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis. 2012;224(2):309–317. doi:10.1016/j.atherosclerosis.2012.05.013
   PubMed Web of Science ®Google Scholar
• Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis. 2011;70(1):8–14. doi:10.1136/ard.2010.142133
   PubMed Web of Science ®Google Scholar
• Attar SM. Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia. Correlation with C-reactive protein levels and disease activity. Saudi Med J. 2015;36(6):685–691. doi:10.15537/smj.2015.6.10557
   PubMed Web of Science ®Google Scholar
• Al-Kaabba AF, Al-Hamdan NA, El Tahir A, et al. Prevalence and correlates of dyslipidemia among adults in Saudi Arabia: results from a national survey. Open J Endocr Metab Dis. 2012;02(04):89–97. doi:10.4236/ojemd.2012.24014
   Google Scholar
• Al-Bishri J, Attar S, Bassuni N, et al. Comorbidity profile among patients with rheumatoid arthritis and the impact on prescriptions trend. Clin Med Insights Arthritis Musculoskelet Disord. 2013;6:11–18. doi:10.4137/CMAMD.S11481
   PubMedGoogle Scholar
• Bawazir YM. Clinicodemographic profiles of rheumatoid arthritis patients from a single center in Saudi Arabia. Open Access Rheumatol. 2020;12:267–275. doi:10.2147/OARRR.S277956
   PubMed Web of Science ®Google Scholar
• Al-Ghamdi A. The co-morbidities and mortality rate among rheumatoid arthritis patients at the western region of Saudi Arabia a retrospective cross-sectional study. J King Abdulaziz Univ Med Sci. 2009;16(3):15–29.
   Google Scholar
• Eastern Health Cluster. Available from: https://ehc.med.sa/en/Pages/default.aspx. Acessed 01 Feburary, 2024. About EHC.
   Google Scholar
• WH Consultation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1–253.
   Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580–1588. doi:10.1136/ard.2010.138461
   PubMed Web of Science ®Google Scholar
• R Core Team. The R Project for Statistical Computing. Available from: https://www.R-project.org/. Accessed July 4, 2024.
   Google Scholar
• Li Y, Cao G, Jing W, Liu J, Liu M. Global trends and regional differences in incidence and mortality of cardiovascular disease, 1990−2019: findings from 2019 global burden of disease study. Eur J Prev Cardiol. 2023;30(3):276–286. doi:10.1093/eurjpc/zwac285
   PubMed Web of Science ®Google Scholar
• Albeladi F, Wahby salem I, Zahrani M, et al. Incidence of coronary artery disease in King Abdulaziz University Hospital, Jeddah, Saudi Arabia, 2019–2020: a retrospective cohort study. Cureus. 2022. doi:10.7759/cureus.28770
   Web of Science ®Google Scholar
• Cho SK, Kim D, Won S, et al. Impact of anti-rheumatic treatment on cardiovascular risk in Asian patients with rheumatoid arthritis. Semin Arthritis Rheum. 2018;47(4):501–506. doi:10.1016/j.semarthrit.2017.08.002
   PubMed Web of Science ®Google Scholar
• Ajeganova S, Andersson MLE, Frostegård J, Hafström I. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study. J Rheumatol. 2013;40(12):1958–1966. doi:10.3899/jrheum.130365
   PubMed Web of Science ®Google Scholar
• Barra LJ, Pope JE, Hitchon C, et al. The effect of rheumatoid arthritis–associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis. Rheumatology. 2017:kew474. doi:10.1093/rheumatology/kew474
   Google Scholar
• Castro AM, Carmona-Fernandes D, Rodrigues AM, et al. Incidence and predictors of cardiovascular events in a cohort of patients with rheumatoid arthritis. Acta Reumatol Port. 2016;41(3):213–219.
   PubMed Web of Science ®Google Scholar
• Pujades-Rodriguez M, Duyx B, Thomas SL, et al. Rheumatoid arthritis and incidence of twelve initial presentations of cardiovascular disease: a population record-linkage cohort study in England. PLoS One. 2016;11(3). doi:10.1371/journal.pone.0151245
   Web of Science ®Google Scholar
• Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543–558. doi:10.1038/s41569-020-0413-9
   PubMed Web of Science ®Google Scholar
• Gao Z, Chen Z, Sun A, Deng X. Gender differences in cardiovascular disease. Med Nov Technol Devices. 2019;4:100025. doi:10.1016/j.medntd.2019.100025
   Google Scholar
• Gerosa M, De Angelis V, Riboldi P, Meroni PL. Rheumatoid arthritis: a female challenge. Womens Health. 2008;4(2):195–201. doi:10.2217/17455057.4.2.195
   Google Scholar
• Chung WS, Lin CL, Peng CL, et al. Rheumatoid arthritis and risk of acute myocardial infarction—A nationwide retrospective cohort study. Int J Cardiol. 2013;168(5):4750–4754. doi:10.1016/j.ijcard.2013.07.233
   PubMed Web of Science ®Google Scholar
• Al-Shenqiti AM, Ibrahim SR, Khaled OA, Ali ARH, Ahmed MS. Incidence of first time stroke: a Saudi experience. Eur Neurol. 2017;77(3–4):147–151. doi:10.1159/000455094
   PubMed Web of Science ®Google Scholar
• Ayoola AE, Banzal SS, Elamin AK, Gadour MO, Elsammani EW, Al-Hazmi MH. Profile of stroke in Gizan, Kingdom of Saudi Arabia. Neurosciences. 2003;8(4):229–232.
   PubMedGoogle Scholar
• Al-Rajeh S, Larbi EB, Bademosi O, et al. Stroke Register: experience from the Eastern Province of Saudi Arabia. Cerebrovascular Dis. 1998;8(2):86–89. doi:10.1159/000015823
   PubMed Web of Science ®Google Scholar
• Al Rajeh S, Awada A, Niazi G, Larbi E; Stroke in a Saudi Arabian National Guard community. Analysis of 500 consecutive cases from a population-based hospital. Stroke. 1993;24(11):1635–1639. doi:10.1161/01.STR.24.11.1635
   PubMed Web of Science ®Google Scholar
• Alhazzani A, Mahfouz A, Abolyazid A, et al. Study of stroke incidence in the Aseer Region, Southwestern Saudi Arabia. Int J Environ Res Public Health. 2018;15(2):215. doi:10.3390/ijerph15020215
   PubMed Web of Science ®Google Scholar
• Alqahtani BA, Alenazi AM, Hoover JC, et al. Incidence of stroke among Saudi population: a systematic review and meta-analysis. Neurol Sci. 2020;41(11):3099–3104. doi:10.1007/s10072-020-04520-4
   PubMed Web of Science ®Google Scholar
• Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107(9):1303–1307. doi:10.1161/01.CIR.0000054612.26458.B2
   PubMed Web of Science ®Google Scholar
• Kang S, Han K, Jung JH, et al. Associations between cardiovascular outcomes and rheumatoid arthritis: a nationwide population-based cohort study. J Clin Med. 2022;11(22):6812. doi:10.3390/jcm11226812
   PubMed Web of Science ®Google Scholar
• Lindhardsen J, Ahlehoff O, Gislason GH, et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ. 2012;344(mar08 2):e1257. doi:10.1136/bmj.e1257
   PubMed Web of Science ®Google Scholar
• AlEidan FAS, AlManea RK, AlMoneef AT, et al. Incidence and predictors of recurrence and mortality following first venous thromboembolism among the Saudi population: single-center cohort study. Int J Gen Med. 2022;15:7559–7568. doi:10.2147/IJGM.S359893
   PubMed Web of Science ®Google Scholar
• Molander V, Bower H, Frisell T, Askling J. Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden. Ann Rheum Dis. 2021;80(2):169–175. doi:10.1136/ANNRHEUMDIS-2020-218419
   PubMed Web of Science ®Google Scholar
• Holmqvist ME, Neovius M, Eriksson J, et al. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA. 2012;308(13):1350. doi:10.1001/2012.jama.11741
   PubMed Web of Science ®Google Scholar
• Liang KP, Liang KV, Matteson EL, McClelland RL, Christianson TJH, Turesson C. Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis Rheum. 2006;54(2):642–648. doi:10.1002/art.21628
   PubMedGoogle Scholar
• Bacani AK, Crowson CS, Roger VL, Gabriel SE, Matteson EL. Increased incidence of atrial fibrillation in patients with rheumatoid arthritis. Biomed Res Int. 2015;2015:809514. doi:10.1155/2015/809514
   PubMed Web of Science ®Google Scholar
• Argnani L, Zanetti A, Carrara G, et al. Rheumatoid arthritis and cardiovascular risk: retrospective matched-cohort analysis based on the RECORD study of the Italian Society for Rheumatology. Front Med. 2021:8. doi:10.3389/fmed.2021.745601
   Web of Science ®Google Scholar
• Kim SC, Liu J, Solomon DH. The risk of atrial fibrillation in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73(6):1091–1095. doi:10.1136/annrheumdis-2013-203343
   PubMed Web of Science ®Google Scholar
• Jang SY, Kang KW, Jo M, Park M. Risk of new-onset acute coronary syndrome and atrial fibrillation in patients with rheumatoid arthritis compared with a risk-set and propensity score-matched cohort― A nationwide cohort study. Circ J. 2021;85(2):194–200. doi:10.1253/circj.CJ-20-0825
   PubMed Web of Science ®Google Scholar
• Nicola PJ, Maradit-Kremers H, Roger VL, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum. 2005;52(2):412–420. doi:10.1002/art.20855
   PubMed Web of Science ®Google Scholar
• Biskup M, Biskup W, Majdan M, Targońska-Stępniak B. Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity. Rheumatol Int. 2018;38(7):1207–1215. doi:10.1007/s00296-018-4053-x
   PubMed Web of Science ®Google Scholar
• Ahlers MJ, Lowery BD, Farber‐Eger E, et al. Heart failure risk associated with rheumatoid arthritis–related chronic inflammation. J Am Heart Assoc. 2020;9(10). doi:10.1161/JAHA.119.014661
   PubMed Web of Science ®Google Scholar
• Ferreira MB, Fonseca T, Costa R, et al. Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: the RA-HF study. Eur J Intern Med. 2021;85:41–49. doi:10.1016/j.ejim.2020.11.002
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med. 2004;116(5):305–311. doi:10.1016/j.amjmed.2003.09.039
   PubMed Web of Science ®Google Scholar
• Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117952. doi:10.1371/journal.pone.0117952
   PubMed Web of Science ®Google Scholar
• National Heart Center‬. Cardiovascular Disease: A Public Health Priority. National Heart Center; 2022.
   Google Scholar
• Kraakman MJ, Dragoljevic D, Kammoun HL, Murphy AJ. Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis. Clin Transl Immunology. 2016;5(5):e84. doi:10.1038/cti.2016.31
   PubMedGoogle Scholar
• Myasoedova E, Crowson CS, Kremers HM, et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011;70(3):482–487. doi:10.1136/ard.2010.135871
   PubMed Web of Science ®Google Scholar
• Alsulami S, Baig M, Ahmad T, et al. Obesity prevalence, physical activity, and dietary practices among adults in Saudi Arabia. Front Public Health. 2023;11:1124051. doi:10.3389/fpubh.2023.1124051
   PubMed Web of Science ®Google Scholar
• Kaplan MJ, McCune WJ. New evidence for vascular disease in patients with early rheumatoid arthritis. Lancet. 2003;361(9363):1068–1069. doi:10.1016/S0140-6736(03)12901-7
   PubMed Web of Science ®Google Scholar
• Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 2002;46(4):862–873. doi:10.1002/art.10089
   PubMed Web of Science ®Google Scholar
• Pasceri V, Yeh ET. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation. 1999;100(21):2124–2126. doi:10.1161/01.cir.100.21.2124
   PubMed Web of Science ®Google Scholar
• Wållberg-Jonsson S, Johansson H, Ohman ML, Rantapää-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol. 1999;26(12):2562–2571.
   PubMed Web of Science ®Google Scholar
• Fraenkel L, Bathon JM, England BR, et al. 2021 American College of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924–939. doi:10.1002/acr.24596
   PubMed Web of Science ®Google Scholar
• Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol. 2015;11(7):390–400. doi:10.1038/nrrheum.2015.40
   PubMed Web of Science ®Google Scholar
• Sattin M, Towheed T. The effect of TNFα-inhibitors on cardiovascular events in patients with rheumatoid arthritis: an updated systematic review of the literature. Curr Rheumatol Rev. 2016;12(3):208–222.
   PubMedGoogle Scholar
• Giollo A, Bissell LA, Buch MH. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review. Expert Opin Drug Saf. 2018;17(7):697–708. doi:10.1080/14740338.2018.1483331
   PubMed Web of Science ®Google Scholar
• Kang EH, Liao KP, Kim SC. Cardiovascular Safety of biologics and JAK inhibitors in patients with rheumatoid arthritis. Curr Rheumatol Rep. 2018;20(7):42. doi:10.1007/s11926-018-0752-2
   PubMed Web of Science ®Google Scholar
• Solomon DH, Reed GW, Kremer JM, et al. Disease activity in rheumatoid arthritis and the risk of cardiovascular events. Arthritis Rheumatol. 2015;67(6):1449–1455. doi:10.1002/art.39098
   PubMed Web of Science ®Google Scholar
• Pujades-Rodriguez M, Morgan AW, Cubbon RM, Wu J. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study. PLoS Med. 2020;17(12):e1003432. doi:10.1371/journal.pmed.1003432
   PubMed Web of Science ®Google Scholar
• Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013;177(4):292–298. doi:10.1093/aje/kws412
   PubMed Web of Science ®Google Scholar